Mitoxantrone.
D000818:Animals; D000880:Anthraquinones / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects; D001943:Breast Neoplasms / Q000188:drug therapy; D004341:Drug Evaluation; D006321:Heart / Q000187:drug effects; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D051379:Mice; D008942:Mitoxantrone; D009374:Neoplasms, Experimental / Q000188:drug therapy
D000880:Anthraquinones; D000970:Antineoplastic Agents; D008942:Mitoxantrone